Robbins Umeda LLP Announces an Investigation of Cymer, Inc.
SAN DIEGO -- October 17, 2012
Shareholder rights firm Robbins Umeda LLP has commenced an investigation into
possible breaches of fiduciary duty and other violations of the law by members
of the board of directors of Cymer, Inc. (NASDAQGS: CYMI) in connection with
their efforts to sell the company to ASML Holding NV (NASDAQADR: ASML).
Concerned shareholders who would like more information about their rights and
potential remedies can contact attorney Gregory E. Del Gaizo at 800-350-6003,
firstname.lastname@example.org, or via the shareholder information form on the firm's
On October 17, 2012, Cymer and ASML announced that they had entered into a
definitive merger agreement under which Cymer will be acquired by ASML.
According to the terms of the deal, ASML will acquire Cymer through a
cash-and-stock transaction with a total value of approximately $2.5 billion
based on ASML's closing stock price on October 16, 2012. Cymer shareholders
will receive a fixed 1.1502 shares of ASML ordinary stock plus $20.00 in cash
in exchange for each share of Cymer ordinary stock. Based on ASML's closing
stock price on October 16, 2012, the implied value of a Cymer share is $81.64.
The acquisition has already been approved by the boards of directors of both
companies. The transaction is expected to close in the first half of 2013.
Robbins Umeda LLP's investigation focuses on whether the board of directors at
Cymer is undertaking a fair process to obtain maximum value and adequately
compensate its shareholders. On July 24, 2012, Cymer reported second quarter
of 2012 results with diluted earnings per share of $0.30 which beat analyst
estimates of $0.04by 600%. The second quarter of 2012 results marked the
seventh time in the previous eight quarters that Cymer had beat analyst
earnings per share estimates and the sixth time in the last eight quarters
that the company's revenue exceed analyst expectations. Given these financial
results, Robbins Umeda LLP is examining the board of directors' decision to
sell Cymer now rather than allow shareholders to continue to participate in
the company's continued success and future growth prospects.
Robbins Umeda LLP attorneys highlight that Cymer shareholders have the option
to file a class action lawsuit against the company to secure the best possible
price for the company's shareholders and the disclosure of material
information to shareholders so they can vote on the transaction in an informed
Robbins Umeda LLP is a nationally recognized leader in securities litigation
and shareholder rights law. The firm represents individual and institutional
investors in shareholder derivative and securities class action lawsuits, and
has helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested. For more information, please go
Press release link:
Attorney Advertising. Past results do not guarantee a similar outcome.
Robbins Umeda LLP
Gregory E. Del Gaizo
619-525-3990 or Toll-Free: 800-350-6003
Press spacebar to pause and continue. Press esc to stop.